• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form 20-F/A filed by Waldencast plc

    11/20/24 4:45:33 PM ET
    $WALD
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $WALD alert in real time by email
    wald-20231231
    0001840199TRUEFY2023USY9xbrli:shares00018401992023-01-012023-12-310001840199dei:BusinessContactMember2023-01-012023-12-310001840199us-gaap:CommonClassAMember2023-01-012023-12-310001840199us-gaap:WarrantMember2023-01-012023-12-310001840199us-gaap:CommonClassAMember2023-12-310001840199us-gaap:CommonClassBMember2023-12-31

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    FORM 20-F/A
    (Amendment No. 1)
    (Mark One)
    oREGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
    OR
    x
    ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934:
    For the fiscal year ended December 31, 2023
    OR
    oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    OR
    oSHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    Commission File Number: 001-40207
    Waldencast plc
    (Exact name of Registrant as specified in its charter)
    Not applicableJersey
    (Translation of Registrant’s name into English)(Jurisdiction of incorporation or organization)
    81 Fulham Road
    London SW3 6
    United Kingdom
    (917) 546-6828
    (Address of principal executive offices)
    Michel Brousset
    Chief Executive Officer
    81 Fulham Road
    London, SW3 6
    United Kingdom
    (917) 546-6828
    (Name, Telephone, Email and/or Facsimile number and Address of Company Contact Person)
    Securities registered or to be registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)
    Name of exchange
    on which registered
    Class A ordinary shares, par value $0.0001 per shareWALDNasdaq Stock Market LLC
    Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per shareWALDWNasdaq Stock Market LLC
    Securities registered or to be registered pursuant to Section 12(g) of the Act: None
    Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
    Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the report:
    On December 31, 2023, the issuer had 122,076,410 ordinary shares outstanding, consisting of 101,228,857 outstanding Waldencast plc Class A ordinary shares, par value $0.0001 per share, and 20,847,553 outstanding Waldencast plc Class B ordinary shares, par value $0.0001 per share.
    Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x
    If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes o No x
    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    Large accelerated fileroAccelerated fileroNon-accelerated filerx
    Emerging growth companyx
    If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. o
    †The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.
    Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting over Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. o
    If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐
    Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). o
    Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:
    U.S. GAAP
    xInternational Financial Reporting Standards as issued by the International Accounting Standards Boardo
    Other
    o
    If “Other” has been checked in response to the previous question indicate by check mark which financial statement item the registrant has elected to follow. Item 17 o Item 18 o
    If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x



    EXPLANATORY NOTE
    Waldencast plc is filing this Amendment No. 1 (the "Amendment") to its Annual Report on Form 20-F for the year ended December 31, 2023, filed with the Securities and Exchange Commission on April 30, 2024 (the “Original Filing”). This Amendment is being filed for the purposes of correcting the certifications of its Principal Executive Officer and Principal Financial Officer required by Rule 13a-14(a), filed as Exhibits 12.1 and 12.2 to the Original Filing, each of which inadvertently omitted language in the introductory portion of paragraph 4 as well as paragraph 4(b). Except as otherwise expressly noted, this Amendment does not modify or update in any way (i) the consolidated financial position, the results of operations or cash flows of Waldencast plc, or (ii) the disclosures in or exhibits to the Original Filing; nor does it reflect events occurring after the Original Filing. Accordingly, this Amendment should be read in conjunction with the Original Filing and Waldencast plc’s other filings made with the SEC subsequent to the Original Filing.
    ITEM 19. EXHIBITS
    EXHIBIT INDEX 
    EXHIBIT
    NUMBER
    DESCRIPTION
    12.1*
    Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
    12.2*
    Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
    104Cover Page Interactive Data File (embedded within the inline XBRL document)
    *Filed herewith.




    SIGNATURE
    The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F/A and that it has duly caused and authorized the undersigned to sign this report on its behalf.
    WALDENCAST PLC
    November 20, 2024By:/s/ Manuel Manfredi
    Name: Manuel Manfredi
    Title: Chief Financial Officer and Principal Financial Officer

    Get the next $WALD alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $WALD

    DatePrice TargetRatingAnalyst
    4/22/2025$5.00Buy
    Alliance Global Partners
    12/16/2024$4.30Hold
    TD Cowen
    10/25/2024$5.00Buy
    Canaccord Genuity
    5/1/2024$10.00 → $8.00Outperform
    Telsey Advisory Group
    7/24/2023Outperform → Mkt Perform
    Raymond James
    9/9/2022$12.00Buy
    DA Davidson
    8/22/2022$11.00Outperform
    Raymond James
    8/17/2022$11.00Buy
    Jefferies
    More analyst ratings

    $WALD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Alliance Global Partners initiated coverage on Waldencast plc with a new price target

      Alliance Global Partners initiated coverage of Waldencast plc with a rating of Buy and set a new price target of $5.00

      4/22/25 9:24:54 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • TD Cowen initiated coverage on Waldencast plc with a new price target

      TD Cowen initiated coverage of Waldencast plc with a rating of Hold and set a new price target of $4.30

      12/16/24 6:40:14 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Canaccord Genuity initiated coverage on Waldencast plc with a new price target

      Canaccord Genuity initiated coverage of Waldencast plc with a rating of Buy and set a new price target of $5.00

      10/25/24 7:48:31 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary

    $WALD
    SEC Filings

    See more
    • SEC Form 6-K filed by Waldencast plc

      6-K - Waldencast plc (0001840199) (Filer)

      7/23/25 6:50:54 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 6-K filed by Waldencast plc

      6-K - Waldencast plc (0001840199) (Filer)

      5/14/25 7:00:36 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 6-K filed by Waldencast plc

      6-K - Waldencast plc (0001840199) (Filer)

      5/13/25 4:05:31 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary

    $WALD
    Financials

    Live finance-specific insights

    See more
    • Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

      Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolio New products position Obagi Medical at the forefront of health, beauty and aesthetics convergence LONDON, July 23, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, today announced that it has acquired Novaestiq Corp. (Novaestiq), a growth-oriented aesthetic and medical dermatological innovations company, as well as the U.S. rights to the Saypha® line of hyaluronic acid (HA) injectable gels. The strategic acquisition expands Obagi Medical's offerings beyond U.S. medical-grade skincare, a marke

      7/23/25 6:45:00 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Waldencast Reports Q1 2025 Financial Results

      Q1 Net Revenue of $65.4 million, (4.1)% decline from Q1 202476.4% Adjusted Gross Margin, an improvement of 10 basis points$4.4 million of Adjusted EBITDA LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended March 31, 2025 ("Q1 2025") on Form 6-K to the U.S. Securities and Exchange Commission (the "SEC"), which are also available on our investor relations site at http://ir.waldencast.com/. Michel Brousset, Waldencast Founder and CEO, said: "As anticipated, in Q1 2025, Milk Makeup results were impacted by the cycling of the very su

      5/13/25 4:15:00 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast

      LONDON, May 06, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform provided the details for its First Quarter Fiscal 2025 conference call and webcast. As previously announced, the Company will issue its First Quarter Fiscal 2025 results on May 13, 2025 after the close of the U.S. market. Management will host a conference call to discuss its First Quarter Fiscal 2025 results on May 14, 2025 at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call will be webcast live and include a slide p

      5/6/25 4:05:49 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary

    $WALD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Waldencast plc (Amendment)

      SC 13D/A - Waldencast plc (0001840199) (Subject)

      2/9/24 6:25:08 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13G filed by Waldencast plc

      SC 13G - Waldencast plc (0001840199) (Subject)

      2/1/24 5:17:40 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Waldencast plc (Amendment)

      SC 13G/A - Waldencast plc (0001840199) (Subject)

      1/31/24 10:23:25 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary

    $WALD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

      Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolio New products position Obagi Medical at the forefront of health, beauty and aesthetics convergence LONDON, July 23, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, today announced that it has acquired Novaestiq Corp. (Novaestiq), a growth-oriented aesthetic and medical dermatological innovations company, as well as the U.S. rights to the Saypha® line of hyaluronic acid (HA) injectable gels. The strategic acquisition expands Obagi Medical's offerings beyond U.S. medical-grade skincare, a marke

      7/23/25 6:45:00 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Shareholders Elect Four Independent Directors to the Six Flags Board

      Six Flags Entertainment Corporation (NYSE:FUN), the largest regional amusement park operator in North America, announced today that its shareholders elected Sandra (Sandy) Cochran, Michael Colglazier, Felipe Dutra, and Steven Hoffman to the Board of Directors of Six Flags Entertainment Corporation for 3-year terms expiring in 2028. Shareholders also confirmed the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm, approved an advisory vote on the compensation of the Company's named executive officers, and confirmed a 1-year frequency for shareholder advisory votes on executive compensation. "I want to welcome Sandy, Michael, Felipe and St

      6/25/25 5:00:00 PM ET
      $BUD
      $CBRL
      $DG
      $FUN
      Beverages (Production/Distribution)
      Consumer Staples
      Restaurants
      Consumer Discretionary
    • Waldencast Reports Q1 2025 Financial Results

      Q1 Net Revenue of $65.4 million, (4.1)% decline from Q1 202476.4% Adjusted Gross Margin, an improvement of 10 basis points$4.4 million of Adjusted EBITDA LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended March 31, 2025 ("Q1 2025") on Form 6-K to the U.S. Securities and Exchange Commission (the "SEC"), which are also available on our investor relations site at http://ir.waldencast.com/. Michel Brousset, Waldencast Founder and CEO, said: "As anticipated, in Q1 2025, Milk Makeup results were impacted by the cycling of the very su

      5/13/25 4:15:00 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary

    $WALD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Waldencast Long-Term Capital Llc

      4 - Waldencast Acquisition Corp. (0001840199) (Issuer)

      7/25/22 12:43:24 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 3 filed by new insider Festetics Tassilo

      3 - Waldencast Acquisition Corp. (0001840199) (Issuer)

      3/7/22 5:00:12 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 3 filed by new insider Chatterley Aaron

      3 - Waldencast Acquisition Corp. (0001840199) (Issuer)

      12/23/21 4:30:38 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary

    $WALD
    Leadership Updates

    Live Leadership Updates

    See more
    • Shareholders Elect Four Independent Directors to the Six Flags Board

      Six Flags Entertainment Corporation (NYSE:FUN), the largest regional amusement park operator in North America, announced today that its shareholders elected Sandra (Sandy) Cochran, Michael Colglazier, Felipe Dutra, and Steven Hoffman to the Board of Directors of Six Flags Entertainment Corporation for 3-year terms expiring in 2028. Shareholders also confirmed the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm, approved an advisory vote on the compensation of the Company's named executive officers, and confirmed a 1-year frequency for shareholder advisory votes on executive compensation. "I want to welcome Sandy, Michael, Felipe and St

      6/25/25 5:00:00 PM ET
      $BUD
      $CBRL
      $DG
      $FUN
      Beverages (Production/Distribution)
      Consumer Staples
      Restaurants
      Consumer Discretionary
    • Milk Makeup to Launch at Ulta Beauty This Spring

      The New York City based award-winning clean color cosmetics brand will expand to select Ulta Beauty stores nationwide and online, marking a significant milestone since its debut in 2016 NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Milk Makeup, the trailblazing clean beauty brand celebrated for its iconic, high-performance formulas, inclusive ethos and part of the Waldencast plc (NASDAQ:WALD) platform, is thrilled to announce an expansion into the nation's largest beauty retailer, Ulta Beauty. Beginning this spring, Milk Makeup's cult-favorite products, including the 13x award-winning Hydro Grip Primer and internet-breaking Cooling Water Jelly Tints will be available in 600+ Ulta Beauty stores nat

      1/28/25 6:45:00 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Waldencast Announces New "Creative Council" of Industry Pioneers and Disruptors

      NEW YORK, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast" or "the Company"), a global multi-brand beauty and wellness platform, today announced the formation of a new Creative Council. The interdisciplinary team of industry disruptors will come together to help Waldencast stay ahead of the curve by ideating on long-term macro and micro-trends in the beauty and wellness industry, and to ensure the Company evolves to meet customer needs now and in the future. The Creative Council will focus on what is next in beauty, wellness, and culture. The goal of the powerhouse group is to provide a pulse on trends and become the dreamers and makers of what these industrie

      2/22/24 9:15:00 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary